The one-and-a-half-day symposium will provide an overview of recent advances in the treatment of solid tumors with novel ...

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Daiichi Sankyo and Merck Launch New Lung Cancer Study With ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and ...

The "Biological Therapies for Cancer: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

Strong balance sheet with cash, cash equivalents, and marketable securities of $208.9 million*, including proceeds from the equity financing, which is anticipated to close on January 13, 2026, and ...

Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...

Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock ...

Cryotherapy Market OverviewThe Cryotherapy Market is projected to grow at a rate of around 7% by 2028, driven by rising incidences of sports injuries and cancer, continuous technological advancements, ...

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026 Phase ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

As an aside, see 3 Risks That Can Make UnitedHealth Stock Unattractive. Additionally, see: MSFT Stock A Winner In 2026? JNJ ...

As global markets navigate a complex landscape, Asian stocks remain a focal point for investors seeking opportunities beyond traditional boundaries. Penny stocks, despite their somewhat outdated ...